Top Swiss court rules that recommended retail prices are anticompetitive
Credit: Shutterstock/Yuriy Maksymiv
Switzerland’s highest court has ruled that Pfizer’s recommended price-lists for an erectile dysfunction drug restricted competition, in a decision that local competition lawyers say creates uncertainty about the legality of recommended resale prices.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now